You’ve got exosomes

<p>Nature Reviews Cancer, Published online: 24 October 2025; <a href="https://www.nature.com/articles/s41568-025-00887-8">doi:10.1038/s41568-025-00887-8</a></p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is an independent risk factor for developing extra-hepatic cancers. Now, Li et al. uncover an exosome-driven metabolic connection between the steatotic liver and the breast that fosters cancer progression.